Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay (Q41647311)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1992

Language	Label	Description	Also known as
English	Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay	scientific article published on January 1, 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

adoptive immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

author name string

K. Kawai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

T. Sasaki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

K. Saijo-Kurita

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

H. Akaza

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

K. Koiso

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

T. Ohno

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511457

3 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1511457

3 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

225-229

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

https://scigraph.springernature.com/pub.10.1007/bf01789327

0 references

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis by activated lymphocytes of melanoma and small cell lung cancer cells surviving in vitro treatment with mafosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of the clonogenic assay for the detection of lymphokine activated killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An enzyme-release assay for natural cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of in vitro methods to determine drug-induced cell lethality

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxicity of acetaminophen and papaverine in primary cultures of rat hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of murine lymphoma cell lysability by CTL and by LAK cells, after treatments with mitomycin C and with adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1511457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01789327

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41647311&oldid=1742286489"